Electrophysiology News and Research

RSS

Electrophysiology: an interview with Dr Kaylene Young

Bioelectricity is an essential part of our make-up. All cells in our body communicate by electrical activity. If an electrical charge is applied to one of our muscles it will interpret that electrical activity as a signal telling it to contract.

21 Nov 2012

Novel electrotherapy reduces energy needed to re-establish normal rhythm in the heart

Implantable defibrillators currently on the market apply between 600 and 900 volts to the heart, almost 10 times the voltage from an electric outlet, says Ajit H. Janardhan, MD, PhD, a cardiac electrophysiology fellow at the Washington University's School of Medicine.

13 Nov 2012

University of Leicester scientists identify unique forms of spinal nerve activity

Scientists from the University of Leicester have hit upon unique forms of spinal nerve activity that shape output of nerve cell networks controlling motor behaviours.

9 Nov 2012

Cardiac arrhythmias: an interview with Dr Andrew Grace

Cardiac arrhythmias are disturbances of the heartbeat. The heart can either go too slowly, which might make people collapse or exhausted; or too quickly.

8 Nov 2012

New data on Posiphen for Alzheimer's disease treatment to be presented at Biotech Symposium

QR Pharma, Inc., a clinical stage specialty pharmaceutical company committed to developing therapeutics with novel approaches for the treatment of Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative disorders, announced today that Dr. Maria Maccecchini, CEO, will be presenting new data on its lead compound "Posiphen® Recovers Memory, Learning and Brain Function in Alzheimer Transgenic Mice" at the 12th Annual Biotech Symposium, taking place October 22, 2012 in Philadelphia, PA.

22 Oct 2012

UMass Amherst neuroscientist to receive 2012 Frank A. Beach Award from SBN

UMass Amherst neuroscientist Luke Remage-Healey will receive the 2012 Frank A. Beach Award from the Society for Behavioral Endocrinology for work showing exceptional promise and significant contributions in the field of behavioral neuroendocrinology. Named after a founder of the field, the award will be presented during the society's annual meeting this week in New Orleans. Remage-Healey will also give a lecture at the society's annual meeting next year.

15 Oct 2012

Inscopix to introduce nVista HD at Neuroscience 2012

Inscopix, Inc. will announce the launch of nVista HD, an end-to-end solution for in vivo brain imaging in freely behaving mice, this weekend at Neuroscience 2012 (SfN).

11 Oct 2012

Boston Scientific enters definitive agreement to acquire Rhythmia Medical

Boston Scientific Corporation has entered into a definitive agreement to acquire privately-held Rhythmia Medical, Inc., a developer of next-generation mapping and navigation solutions for use in cardiac catheter ablations and other electrophysiology procedures, including atrial fibrillation and atrial flutter.

9 Oct 2012

St. Jude Medical launches 3-D navigation system that reduces need for live fluoroscopy

St. Jude Medical, Inc., a global medical device company, today announced the launch of its MediGuide Technology, the first and only three-dimensional (3-D) navigation system intended for the evaluation of vascular and cardiac anatomy on a recorded fluoroscopic image instead of live fluoroscopy (a series of X-ray images).

8 Oct 2012

FDA panel recommends U.S. approval for Second Sight’s Argus II bionic eye

On Friday September 28th, a U.S. Food and Drug Administration (FDA) Ophthalmic Devices Advisory Panel unanimously voted 19-0 that the probable benefit of the Argus II Retinal Prosthesis System outweighs the risks to health, an important step toward the FDA market approval of this product manufactured by Second Sight Medical Products, Inc.

3 Oct 2012

Clemson University launches Medical Device Recycling and Reprocessing Certificate Program

Clemson University has established the first program to train engineers to recycle and reprocess medical devices. The Medical Device Recycling and Reprocessing Certificate Program offered by the Clemson University Biomedical Engineering Innovation Campus (CUBEInC) was developed in response to the dramatic market adoption of reprocessing in recent years.

3 Oct 2012

Methodist Health System celebrates latest expansion in North Texas

Today Methodist Health System celebrated its latest expansion in North Texas during a groundbreaking ceremony for the Methodist Richardson Medical Center – Bush/Renner hospital.

28 Sep 2012

Boston Scientific receives regulatory approval to market RELIANCE 4-FRONT in Europe and Asia

Boston Scientific Corporation has received regulatory approval to market the RELIANCE 4-FRONT lead, its next generation implantable defibrillation lead now available in Europe and Asia. Defibrillation leads are insulated wires that connect an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy defibrillator to the heart for treatment of heart failure and sudden cardiac arrest.

24 Sep 2012

Posterior medial cortex more specifically engaged in recall or imagination

You already know it's hard to balance your checkbook while simultaneously reflecting on your past. Now, investigators at the Stanford University School of Medicine - having done the equivalent of wire-tapping a hard-to-reach region of the brain - can tell us how this impasse arises.

4 Sep 2012

Glaucoma and cell death: an interview with Dr. Vivek Gupta

Glaucoma is normally caused by increased pressure of aqueous humour fluid in the eye. A defining feature of this disease is destruction of a particular type of cells in the retina called retinal ganglion cells and excavation of the optic disc region.

31 Aug 2012

EHRA White Book reports on current status of arrhythmia treatments in 54 ESC member countries

The analysis was conducted using five editions of the EHRA White Book, which is produced by the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC).

30 Aug 2012

Heart Rhythm Society, ECAS and EHRA develop 2012 expert consensus statement on AF ablation

The 2012 expert consensus statement on catheter and surgical ablation of atrial fibrillation was developed by the Heart Rhythm Society (HRS), the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC), and the European Cardiac Arrhythmia Society (ECAS) and published in their respective journals: Heart Rhythm, EP Europace and the Journal of Interventional Cardiovascular Electrophysiology (JICE).

30 Aug 2012

Baylor Plano first hospital to merge MEM software and Epoch platform for atrial fibrillation therapy

Baylor Plano became the first hospital in the world on Friday to merge two highly advanced technologies for atrial fibrillation therapy.

27 Aug 2012

New drug may be useful in treating long QT syndrome

Johns Hopkins researchers have discovered a new drug that may be useful in treating a heart rhythm condition called long QT syndrome.

1 Aug 2012

New drug shows promise for Long QT syndrome

Long QT syndrome, which results from genetic mutation or certain medications, can cause the heart to beat chaotically and the affected person to die suddenly. The chaotic heartbeat is due to abnormal electrical activity in the heart. In an electrocardiogram test, this abnormality appears as a wider-than-normal QT interval, a pattern of "hills" in a map of peaks and valleys corresponding to the heart contracting and relaxing.

30 Jul 2012